Concepedia

Vittavat Termglinchan

VT

11

Publications

1.5K

Citations

11

H-Index

2015

Active since

Affiliations

Stanford University(Current)

Cardiovascular Institute of the South

German Centre for Cardiovascular Research

Max Delbrück Center

Howard Hughes Medical Institute

Vittavat Termglinchan is an author at Stanford University specializing in medicine, cardiac reprogramming, and cell biology.

Top concepts

MedicineCardiac ReprogrammingCardiologyCell BiologyGene ExpressionCardiac Progenitor CellsHeart FailureCell SignalingMolecular PhysiologyGenetics

Publications per year

2015–2022

11

Publications

11

Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy

Jaecheol Lee, Vittavat Termglinchan, Sebastian Diecke et al. · Nature · 2019 · 212 citations

Cardiac Muscle, Cardiomyopathy, Heart Failure +8

Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers

Mingxia Gu, Ning‐Yi Shao, Silin Sa et al. · Cell stem cell · 2016 · 205 citations · Full text

Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy

Ioannis Karakikes, Francesca Stillitano, Mathieu Nonnenmacher et al. · Nature Communications · 2015 · 185 citations · Full text

iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy

Kazuki Kodo, Sang-Ging Ong, Fereshteh Jahanbani et al. · Nature Cell Biology · 2016 · 171 citations · Full text

Abnormal Tgf-β Signalling, Cardiac Muscle, Heart Failure +13

Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo

Nigel G. Kooreman, Youngkyun Kim, Patrícia E. de Almeida et al. · Cell stem cell · 2018 · 168 citations · Full text

Vaccination, Tumor Immunology, Immunology +4

Rows per page

1–5 of 11